Detalhe da pesquisa
1.
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity.
J Clin Immunol
; 43(4): 680-691, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795264
2.
Systemic vasculitis: one year in review 2023.
Clin Exp Rheumatol
; 41(4): 765-773, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37073639
3.
Systemic vasculitis: one year in review 2022.
Clin Exp Rheumatol
; 40(4): 673-687, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35522544
4.
Timing of rituximab and immunoglobulin level influence the risk of death for COVID-19 in ANCA-associated vasculitis.
Rheumatology (Oxford)
; 60(7): 3476-3477, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33609106
5.
Unmet needs in ANCA-associated vasculitis: Physicians' and patients' perspectives.
Front Immunol
; 14: 1112899, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36911748
6.
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC).
Clin Rheumatol
; 42(2): 359-370, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36169798
7.
Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 Outbreak.
Viruses
; 14(7)2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35891442
8.
Diagnosis and management of lung involvement in systemic lupus erythematosus and Sjögren's syndrome: a literature review.
Ther Adv Musculoskelet Dis
; 13: 1759720X211040696, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34616495
9.
Correction to: Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC).
Clin Rheumatol
; 42(2): 641-642, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36264401